Similar trends were observed in the five NSCLC cells with perifosine at 1 or 10 μM, as well as with another Akt inhibitor LY294002 used as a reference inhibitor in vitro (data not shown). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.